Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > I’m bullish.

<< Previous

Bullboard Posts

Next >>

Post by Rarbar99on Aug 20, 2021 11:05am

312 Views

Post# 33739663

I’m bullish.

I was bearish when this was in the 1.40-1.55 range, and as I predicted, it dropped back to the low 1s just a week later.

but yesterday, after some more research, I clearly stated that I'm a bull now.

I do believe in this company and will hold my shares, even if they eventually go bankrupt and this stock goes to $0

i Won't buy anymore shares until October though. I want to see a little more stabilization before I start investing serious cash into this.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments